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Increased Aβ pathology in aged 
Tg2576 mice born to mothers fed a 
high fat diet
Shereen Nizari1, Roxana O. Carare2 & Cheryl A. Hawkes1
Maternal obesity is associated with increased risk of developing diabetes, obesity and premature death 
in adult offspring. Mid-life diabetes, hypertension and hypercholesterolaemia are risk factors for the 
development of sporadic Alzheimer’s disease (AD). A key pathogenic feature of AD is the accumulation 
of β-amyloid (Aβ) in the brain. The purpose of this study was to investigate the effect of high fat diet 
feeding during early life on Aβ pathology in the Tg2576 mouse model of AD. Female mice were fed a 
standard (C) or high fat (HF) diet before mating and during gestation and lactation. At weaning, male 
offspring were fed a C diet. Significantly higher levels of guanidine-soluble Aβ and plaque loads were 
observed in the hippocampi of 11-month old Tg2576 mice born to mothers fed a HF diet. Changes in the 
extracellular matrix led to increased retention of Aβ within the parenchyma. These data support a role 
for maternal and gestational health on the health of the aged brain and pathologies associated with AD 
and may provide a novel target for both the prevention and treatment of AD.
Over 2.1 billion adults are currently estimated to be overweight or obese, of which approximately 38% are women 
of childbearing age1. Obesity is associated with an intake of diets that are high in saturated fat, typical of a Western 
diet2,3. A large body of experimental and epidemiological evidence supports a relationship between maternal diet, 
gestational environment and health in adulthood4. In particular, maternal obesity is associated with increased risk 
of coronary heart disease, diabetes, obesity, attention deficit hyperactivity disorder and premature death in adult 
offspring5–7. However, there is sparse evidence on how maternal obesity affects the susceptibility to neurodegen-
erative diseases such as Alzheimer’s disease (AD).
In addition to advanced age, the presence of diabetes, hypertension and hypercholesterolemia in mid-life 
increases the risk of developing AD8. AD is characterized pathologically by the intracellular accumulation of 
tau and the extracellular deposition of β -amyloid (Aβ ) peptides in the parenchyma as plaques and in the walls 
of arteries and capillaries as cerebral amyloid angiopathy (CAA)9. Aβ 42 is predominantly found in parenchymal 
plaques, while CAA is composed principally of Aβ 4010. Aβ peptides of 38–42 amino acids are produced follow-
ing the proteolytic cleavage of the amyloid precursor protein (APP) by β - and γ -secretase. Removal of Aβ from 
the brain is mediated by several mechanisms, including enzymatic cleavage by neprilysin and insulin degrading 
enzyme (IDE), uptake by microglia and perivascular macrophages, transcytosis across the blood-brain barrier 
and perivascular drainage along basement membranes of capillaries and arteries11–16.
Cerebrovascular basement membranes (CVBM) are specialized sheets of extracellular matrix that are com-
posed of laminins, collagen IV and heparin sulphate proteoglycans such as perlecan and fibronectin and are in 
direct communication with the extracellular spaces of the parenchyma17. The composition of CVBM and the 
extracellular matrix influence the kinetics of Aβ aggregation. In particular, laminin, nidogens and collagen IV 
inhibit the aggregation of Aβ and destabilize pre-formed fibrils, while fibronectin and perlecan accelerate the 
aggregation of Aβ via high-affinity interactions18–20. In the aged and AD brain, there is a shift in the relative 
expression of basement membrane proteins towards those that promote Aβ aggregation, which contributes to a 
failure of perivascular drainage of Aβ from the brain and the development of CAA and dementia13,21–26.
The correlation between maternal obesity and the development of metabolic syndrome in adulthood and the 
increased risk of AD in individuals with metabolic syndrome in mid-life, suggests that a link may exist between 
maternal obesity and increased risk of AD. In a previous related study we demonstrated that maternal high fat 
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diet resulted in failure of perivascular clearance of Aβ in normal offspring27. The aim of the current study was to 
investigate the effect of prenatal high fat diet exposure on Aβ pathology in the Tg2576 mouse model of AD.
Results
Prenatal HF increases levels of guanidine-soluble Aβ40 and Aβ42. To determine the effect of early 
life high fat feeding on levels of Aβ , the hippocampi of 11-month old Tg2576 mice born to mothers fed a nor-
mal (C/C) and high fat diet (HF/C) were analysed for TBS- and guanidine-soluble human Aβ 40 and Aβ 42 by 
ELISA28. No differences were detected in the levels of TBS-soluble Aβ 40 or Aβ 42 between C/C and HF/C off-
spring (Fig. 1a,c). However, levels of guanidine-soluble Aβ 40 and Aβ 42 were both significantly higher in the 
Figure 1. (a–d) Levels of hippocampal TBS-soluble human Aβ 40 (a) and Aβ 42 (c) did not differ between 
11-month old C/C and HF/C Tg2576 mice. However, HF/C mice had significantly higher levels of guanidine-
soluble Aβ 40 (b) and Aβ 42 (d) compared to C/C animals. (e) The plasma ratio of Aβ 42:Aβ 40 was also higher in 
HF/C vs. C/C mice. *p < 0.05.
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brains of HF/C mice compared to C/C animals (Fig. 1b,d). Plasma Aβ 42/40 ratios were also significantly elevated 
in HF/C vs. C/C mice (Fig. 1e).
Parenchymal Aβ40 plaque load and size are increased in HF/C mice. To confirm that the elevated 
levels of guanidine-soluble Aβ in HF/C mice were associated with increased Aβ pathology, brains tissue sections 
were processed for immunohistochemistry using antibodies against human Aβ 40 and Aβ 42. A few Aβ -positive 
dense-core parenchymal plaques were observed in the hippocampus of both C/C and HF/C mice, consistent with 
the amount of insoluble plaque deposition at this age29 (Fig. 2a–d). The percentage area covered by Aβ 40-positive 
plaques within the hippocampus was significantly higher in HF/C mice compared to C/C offspring (Fig. 2e). A 
similar, but non-significant trend was also observed for Aβ 42 (Fig. 2f). Analysis of average plaque size showed 
that Aβ 40- and Aβ 42-positive plaques were approximately 5.5 and 6.1 times larger, respectively, in HF/C mice 
than those observed in C/C animals (Fig. 2g,h).
APP levels are decreased in HF/C mice. Elevated levels of Aβ may be due to increased APP processing 
and/or decreased Aβ clearance from the brain. To determine if levels of APP were altered between C/C and HF/C 
mice, hippocampi from Tg2576 mice were processed by Western blotting with antibodies against full-length and 
C-terminal fragments of APP (APP-CTF), Aβ 1-16, BACE and the γ -secretase component nicastrin. Levels of 
full-length APP and APP-CTFβ were significantly decreased in the brains of HF/C mice, while levels of 4 kDa Aβ 
were increased (Fig. 3a–e). An increase in nicastrin expression, which bordered statistical significance (p = 0.05), 
was also noted in HF/C animals (Fig. 3g,i). Levels of BACE did not differ between offspring groups (Fig. 3h,j).
Diffusion of Aβ within the extracellular matrix is reduced in HF/C mice. To determine whether the 
clearance of Aβ was affected by prenatal exposure to high fat, the levels of enzymes that degrade Aβ (neprilysin, 
insulin degrading enzyme (IDE)), the endothelial transporter low-density receptor-related protein-1 (LRP-1), as 
well as basement membrane proteins collagen IV and fibronectin were assessed by Western blotting. No signif-
icant differences were noted in the levels of LRP-1, neprilysin or IDE between C/C and HF/C mice (Fig. 4a–f). 
Collagen IV expression was also unchanged between diet groups (Fig. 4g,i). However, levels of fibronectin were 
significantly higher in the hippocampi of HF/C mice compared to the C/C group (Fig. 4j,j).
We have previously shown that cerebrovascular basement membranes are an extension of the parenchymal 
extracellular matrix17 and act as lymphatic drainage pathways along which Aβ is removed from the brain13. 
Failure of this clearance mechanism contributes to the accumulation of Aβ as CAA25. To evaluate if vascular Aβ 
was also affected by prenatal HF exposure, CAA severity was evaluated in cortical leptomeningeal arteries. As 
demonstrated in Fig. 5, vessel coverage by Aβ 40-positive CAA was significantly lower in HF/C mice than in C/C 
mice (Fig. 5a–c). Quantification of Aβ 42-positive vascular deposits was not possible as these deposits were rarely 
observed in both C/C and HF/C mice.
To determine if reduced CAA severity was due to diet-induced changes in the extracellular matrix that 
increase the retention of Aβ in the parenchyma, we first evaluated the distribution of fibronectin in the hippocam-
pus of C/C and HF/C mice by immunohistochemistry. Consistent with the Western blotting data, fibronectin 
staining covered a significantly higher percentage of the hippocampus in HF/C mice compared to C/C animals 
(Fig. 6a–c). To evaluate if the diffusion of Aβ within the extracellular matrix was affected by HF diet independent 
of plaque pathology, 5-month old wildtype C/C and HF/C mice were injected with human Aβ 40. Within 5 min-
utes post-injection, the majority of the Aβ had diffused away from the injection site of C/C mice (Fig. 6d). Over 
the same time period, significantly more Aβ was retained in the hippocampi of HF/C mice, as indicated by the 
increased amount of fluorescence measured at the site of injection (Fig. 6e,f).
Discussion
Maternal diet is key for the long-term health of the offspring30. In the present study, we found that 11-month 
old Tg2576 mice born to mothers fed a high fat diet during gestation and lactation developed higher levels 
of guanidine-soluble Aβ and hippocampal plaque load compared to mice born to mothers on a normal diet. 
Increased Aβ pathology was due in part to a failure of diffusion and increased retention of Aβ within the paren-
chyma. These data support a key role for early life environment on the health and function of the aged brain and 
pathologies associated with AD.
The risk of developing sporadic AD is influenced by modifiable factors such as smoking, obesity, and physical 
and cognitive activity31. Among these risk factors, obesity has emerged as a global issue, with approximately 40% 
of all adults currently estimated to have a body mass index over 25kg/m2 1. The majority of studies investigating 
the link between obesity and risk of AD have used models of postnatal high fat diet feeding. Pathological features 
related to AD, in association with decreased cognitive function have been reported in various transgenic mouse 
models of AD following consumption of diets high in saturated fats and/or cholesterol32–35.
Despite the established link between maternal obesity and the development in adulthood of conditions that 
themselves increase the risk of AD, such as obesity and diabetes8,36, very little work has been done to investigate 
the relationship between maternal obesity and risk of AD. We have previously reported that exposure to a high 
fat diet during brain development affects the expression of markers of the neurovascular unit and impairs the 
efficiency of Aβ clearance from the brain along cerebral basement membranes in adult offspring27. The present 
study expands upon these findings by demonstrating that Aβ pathology is higher in Tg2576 mice born to obese 
mothers, due in part to increased retention of Aβ in the parenchyma. Although Aβ production may also have 
been affected in HF/C mice, more detailed experiments are needed to definitively determine if the observed 
increase in levels of 4-kDa Aβ were due to increased APP processing or increased retention.
The findings of this study are in contrast to those of Martin et al.37, who reported decreased cognitive perfor-
mance of 12-month old female 3xTg mice exposed to a high fat diet during gestation and lactation in the absence 
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Figure 2. (a–d) Photomicrographs of staining of Aβ 40- (a,b) and Aβ 42-positive plaques (c,d) in the 
hippocampus of C/C (a,c) and HF/C (b,d) 11-month old Tg2576 mice. (e–h) Both percentage area and average 
size of Aβ 40-positive plaques was significantly higher in HF/C mice compared to C/C offspring (e, g) with a 
similar non-significant trend observed for Aβ 42 (f,h). Scale bar = 500 μ m. *p < 0.05.
www.nature.com/scientificreports/
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of changes in Aβ plaque load. Although the reasons for this discrepancy are unknown, they may relate to differ-
ences in diet composition, sex and/or transgene expression. Nevertheless, both studies support a role for maternal 
obesity in the etiology of AD-related pathology.
We have previously demonstrated that Aβ contained with the interstitial fluid of the brain is rapidly cleared 
from the parenchyma along cerebrovascular basement membranes which invaginate the extracellular space13,17,38. 
Impaired elimination of Aβ and other metabolites along perivascular pathways is hypothesized to trigger the rise 
in Aβ oligomers that drives the amyloid cascade with seeding of Aβ plaques, hyperphosphorylation of tau and 
propagation of neurofibrillary tangles, leading to synaptic dysfunction and death39. Changes in the glycoprotein 
and proteoglycan composition of the basement membrane and extracellular matrix influence the kinetics of Aβ 
aggregation and the efficiency by which Aβ is removed from the brain21–25. In particular, incubation of Aβ with 
fibronectin in vitro accelerates fibril formation21 and increased expression of vascular fibronectin has been shown 
to precede the development of CAA in vivo40. In the present study, fibronectin expression was increased in HF/C 
mice in association with decreased diffusion of Aβ within the extracellular matrix at 5 minutes after injection, 
suggesting that Aβ was retained within the parenchyma of HF/C mice. This is further supported by the findings 
that the parenchymal plaques in HF/C mice were significantly larger than those in C/C mice and that CAA 
severity in cortical leptomeningeal vessels was decreased in HF/C mice. This is in agreement with our previous 
findings that perivascular drainage of Aβ is disrupted in the presence of pre-existing plaques, which are bound by 
solutes contained within the ISF25. Collectively, these results suggest that early life exposure to a HF diet resulted 
Figure 3. (a–c) Levels of full-length APP were significantly decreased and levels of 4 kDa Aβ were increased in 
the hippocampus of 11-month old Tg2676 HF/C mice compared to C/C mice. (d,e) Levels of APP-CTFβ were 
also significantly decreased in the brains of HF/C mice (d, e) while APP-CTFα levels were unaltered between 
diet groups. (g–j) An increase in nicastrin expression, which bordered statistical significance (p = 0.05), was 
also noted in HF/C animals (g–i). No significant differences were noted in the levels of BACE (h,j). *p < 0.05, 
**p < 0.01.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:21981 | DOI: 10.1038/srep21981
Figure 4. (a–f) Levels of hippocampal expression of LRP-1 (a,d), neprilysin (b,e) and IDE (c,f) did not differ 
between C/C and HF/C mice. (g–j) Levels of collagen IV (g,i) were also unaltered between offspring groups. 
However fibronectin levels were significantly higher in the hippocampus of HF/C mice compared to C/C 
offspring (h,j). **p < 0.01.
Figure 5. (a,b) Photomicrographs of Aβ 40-positive CAA staining in cortical leptomeningeal vessels of 11-
month old C/C (a) and HF/C (b) Tg2576 mice. (c) Vessel coverage by Aβ 40-positive staining was significantly 
lower in HF/C mice than in C/C mice. Scale bar = 500 μ m. *p < 0.05.
www.nature.com/scientificreports/
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in alterations in the extracellular matrix and lead to the retention of Aβ within the parenchyma. However, as the 
present study used only one time point to evaluate the diffusion of Aβ from the parenchyma, further work is 
needed to determine the time-course of Aβ clearance from the brains of HF/C mice.
Findings from the present study support the Latent Early-Life Associated Regulation hypothesis of AD pro-
posed by Lahiri et al.41–43, which suggests that maternal diet influences early epigenetic changes that contribute 
to disease susceptibility in late life. As the incidence of obesity continues to rise in both girls and women of 
childbearing age1, it is imperative that the epigenetic and biochemical pathways that are influenced by maternal 
obesity are identified. Such information may provide a novel target for both the prevention and treatment of AD.
Methods
Mouse prenatal high fat feeding. Female C57Bl/6 and SJLxC57Bl/6 mice were fed a standard (C, 20% 
kcal fat, 17% kcal protein, 63% kcal carbohydrate, n = 6) or high fat diet (HF, 45% kcal fat, 20% kcal protein, 35% 
kcal carbohydrate; Special Diet Services, UK, n = 6), for four weeks before mating, as described previously27. 
Females were then mated with either wildtype or Tg2576 male mice. Tg2576 mice express the human Swedish 
APP mutation and show elevated levels of SDS-insoluble Aβ starting at 6 months of age29. Diffuse parenchymal 
plaques appear around 10 months of age in the cortex and hippocampus and as CAA in cortical leptomeningeal 
arteries29. Dams were kept on the diet during gestation and lactation, with litters standardized to 8 pups to avoid 
nutritional biases. Male offspring were fed a C diet from weaning, generating 2 offspring groups, C/C and HF/C, 
representing the pre- and post-weaning diet. Wildtype mice were aged to 5 months while the Tg2576 offspring 
were sacrificed at 11 months of age. All animal experiments were approved by the local Animal Welfare and 
Ethical Review Body at the University of Southampton and carried out in accordance with approved guidelines 
of the Home Office (30/3095).
Sandwich Aβ ELISA. Tg2576 mice (n = 3/group) were perfused intracardially with 0.01M phosphate buff-
ered saline (PBS), brains rapidly removed and snap frozen. The hippocampus was dissected and sonicated in TBS 
extraction buffer (140 mM NaCl, 3 mM KCl, 25 mM Tris (pH 7.4), 1% Nonidet P-40, 5 mM EDTA) containing a 
protease inhibitor cocktail (Sigma Aldrich, Gillingham, UK). Homogenates were centrifuged (20 820 g, 15 mins, 
4 °C) and supernatant collected as the soluble fraction. Pellets were sonicated in 5M guanidine HCl in 50 mM Tris 
(pH 8.0), incubated for 3 hours at room temperature, spun down (20 820 g, 20 mins, 4 °C) and supernatant col-
lected as the guanidine-soluble fraction. Samples were diluted and analyzed using commercially available sand-
wich ELISA kits (Life Technologies, Paisley, UK) as per manufacturer’s instructions. Plasma samples obtained 
immediately after sacrifice were also assessed for Aβ levels. Samples were measured in duplicate, with mean 
values ± S.E.M. reported for treatment groups.
Figure 6. (a–c) Photomicrographs of fibronectin staining in the hippocampus of 11-month old C/C (a) and 
HF/C (b) Tg2576 mice. Fibronectin covered a significantly greater area in HF/C mice compared to C/C animals 
(c). (d,e) Photomicrographs of exogenous HilyteFluor-488 human Aβ 40 injected into the hippocampus of 
5-month old wildtype C/C (d) and HF/C mice (e). (f) Significantly more Aβ was retained at the injection site in 
the hippocampi of HF/C mice, as indicated by the increased mean fluorescence intensity measured at the site of 
injection. Scale bars: a and b = 500 μ m, d and e = 400 μ m. *p < 0.05.
www.nature.com/scientificreports/
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Immunohistochemistry. Mice (n = 5/group) were perfused intracardially with 0.01M PBS, followed by 
4% paraformaldehyde, brains removed and post-fixed overnight. For enzyme-linked immunohistochemistry, 
brain tissue sections were washed in 0.01M PBS, treated with formic acid (70%, 30 sec) and incubated overnight 
at 4 °C with antibodies against human anti-Aβ 40 (1:250, Merck Millipore, Watford, UK) and anti-Aβ 42 (1:250, 
Merck Millipore). Sections were washed in 0.01M PBS, incubated with biotinylated anti-rabbit (1:400, Vector 
Labs, Peterborough, UK) and developed using glucose oxidase enhancement with DAB as chromagen. For flu-
orescent immunohistochemistry, tissue sections were washed in 0.01M PBS, treated with 1 mg/mL pepsin in 
0.2N HCl (45 sec, 37 °C) and incubated overnight at 4 °C with anti-fibronectin (1:400, AbD Serotec, Kidlington, 
UK). Sections were washed in 0.01M PBS, incubated 2 hrs with AlexaFluor 488-conjugated anti-rabbit (1:200; 
Life Technologies) and coverslipped with mowiol. Images were captured on a Nikon microscope and exported to 
Photoshop CS. For quantification of percentage area covered by staining, micrographs were converted to binary 
images, thresholded to eliminate background staining and evaluated by densitometry using Image J software 
(NIH, Maryland, USA).
Western blotting. The hippocampi of Tg2576 mice (n = 3/group) were sonicated in Ripa lysis buffer (20 mM 
Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Igepal, 50 mM NaF, 1 mM NaVO3) containing 
a protease inhibitor cocktail. Proteins (15–45 μ g) were separated by gel electrophoresis on 3–8% Tris-acetate 
or 10–20% Tris-Tricine gels (Life Technologies), transferred to nitrocellulose membranes and incubated with 
the following antibodies: anti-APP CTF (1:1000, BioLegend, London, UK), anti-Aβ 1-16 (clone 6E10, 1:500, 
BioLegend), anti-nicastrin (1:500, New England Biolabs, Hitchin, UK), anti-β -secretase-1 (BACE, 1:750, New 
England Biolabs), anti-low-density receptor-related protein-1 (LRP-1, 1:2500, Insight Biotechnology, Wembley, 
UK), anti-IDE (1:750, Abcam, Cambridge, UK), anti-neprilysin (1:500, Abcam, Cambridge, UK), anti-fibronectin 
(1:750, AbD Serotec) and anti-collagen IV (1:500, Sigma Aldrich). Membranes were stripped and reprobed 
with anti-glyceraldehyde-3-PDH (GAPDH) antibody (1:50,000; Sigma Aldrich) to ensure equal protein load-
ing. Immunoblots were repeated twice per antibody and quantified by densitometry using Image J software. 
Means ± S.E.M. were calculated as an optical density ratio of protein levels normalized to GAPDH levels.
Intracerebral injections. Wildtype mice (n = 5/group) were injected stereotaxically with HilyteFluor-488 
human Aβ 40 (100 μ M, 0.5 μ L, Anaspec, Fremont, USA) into the left hippocampus (coordinates from Bregma: 
AP = − 1.9 mm; ML = 1.5 mm and DV = 1.7 mm). Injection pipettes were left in situ for 2 minutes to prevent 
reflux and mice were sacrificed 5 minutes post-injection. Mice were perfused intracardially with 0.01M PBS, 
followed by 4% paraformaldehyde, brains sectioned and coverslipped with Mowiol containing citiflor anti-fading 
reagent. Images were captured on a Nikon microscope and exported to Image J. The size of Aβ bolus was quanti-
fied by subtracting the mean grey value intensity of Aβ at the site of injection from the mean grey value intensity 
of the contralateral, non-injected hippocampus. Intensity values were then divided by the total hippocampal area 
of each section and expressed as mean intensity/μ m2.
Statistical analysis. All mice were coded and measurements were carried out in a blinded fashion. Data 
obtained from ELISA and immunohistochemistry experiments were analyzed using a one-tailed Student’s t-test, 
where Aβ pathology was predicted to be greater in the HF/C group. Western blot and injection site data were 
analyzed using a two-tailed Student’s t-test. All data are presented as mean ± S.E.M. and in all cases significance 
was set at p < 0.05. Analyses were carried using GraphPad Prizm software.
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